Drug intelligence / Profile preview

piyanling liniment

Development stage
Preclinical
Lead developer
The 71st Group Army Hospital of the CPLA Army
Modality
Small Molecules
Administration
Topical
01

Overview

Piyanling liniment is a topical pharmaceutical preparation developed by the 71st Group Army Hospital of the Chinese People's Liberation Army (CPLA), formerly known as the 97th Hospital. It is a hospital-made preparation (医院制剂) specifically formulated for the treatment of chronic inflammatory and pruritic skin conditions, including neurodermatitis and chronic eczema. The formulation typically functions as a combination therapy, utilizing a corticosteroid (such as dexamethasone) to provide potent anti-inflammatory and immunosuppressive effects, alongside antipruritic agents like camphor and menthol which offer cooling and soothing relief from itching. It may also contain salicylic acid for its keratolytic properties, which help to soften and remove thickened skin scales. As a liniment (spirit-based solution), it is designed for topical application to facilitate the penetration of active ingredients into the affected dermal layers.

Brand names
Piyanling liniment
Other names
皮炎灵醑Pi Yan Ling Xu
02

Targets

GR (Glucocorticoid receptor)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on piyanling liniment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on piyanling liniment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call